Exploring Treatment Options for Treatment-Resistant Depression
Treatment-resistant depression remains a significant challenge, prompting the exploration of various therapeutic options. These include esketamine nasal spray, transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT). Esketamine is FDA-approved for adults who have not responded to at least two oral antidepressants, while TMS uses magnetic pulses to stimulate mood-regulating brain regions without anesthesia. ECT, a more established treatment, involves controlled electrical stimulation under anesthesia. Each option offers different benefits and is considered based on individual patient needs and previous treatment responses. 
